Catalyst
Slingshot members are tracking this event:
FDA Grants Orphan Designation to Eiger Bio's (EIGR) Exendin 9-39 in Hyperinsulinemic Hypoglycemia
- Source Link:
- http://www.eigerbio.com/category/press-releases/
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EIGR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Orphan Designation, Exendin 9-39, Hyperinsulinemic Hypoglycemia
